A cell-based screen for drugs to treat Huntington's disease
- 14 May 2004
- journal article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 16 (3), 546-555
- https://doi.org/10.1016/j.nbd.2004.04.001
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Neurologists strike gold in drug screen effortNature, 2002
- Impairment of the Ubiquitin-Proteasome System by Protein AggregationScience, 2001
- α-Synuclein overexpression promotes aggregation of mutant huntingtinBiochemical Journal, 2000
- Analysis of the Role of Heat Shock Protein (Hsp) Molecular Chaperones in Polyglutamine DiseaseJournal of Neuroscience, 1999
- The Influence of Huntingtin Protein Size on Nuclear Localization and Cellular ToxicityThe Journal of cell biology, 1998
- Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell cultureHuman Molecular Genetics, 1998
- Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD MutationCell, 1997
- Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neuronsNeuron, 1995
- Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.Proceedings of the National Academy of Sciences, 1976
- Physicochemical Properties, Solubility, and Protein Binding of Δ9 -TetrahydrocannabinolJournal of Pharmaceutical Sciences, 1974